Zusammenfassung
Die atopische Dermatitis(AD) ist in den westlichen Industrieländern deutlich auf dem Vormarsch. Neue Erkenntnisse in Bezug auf die Pathogenese der Erkrankung spiegeln sich auch in einer veränderten Terminologie, vorgeschlagen von der World Allergy Organization: eine Aufteilung in eine atopische und eine nichtatopische Dermatitis. Die Pathogenese der AD, auf die sich dieser Beitrag konzentriert, ist sehr komplex. Genetische Faktoren spielen zusammen mit Umweltfaktoren eine wichtige Rolle bei der Triggerung der AD. Das komplexe Muster an Zytokinen und Chemokinen, das eine veränderte Immunantwort der AD-Patienten widerspiegelt, findet bei der Erforschung dieser Erkrankung ebenso Beachtung wie die Beteiligung der verschiedensten Zellen und der epidermalen Barriere. Auch die Erforschung von T-Zellen mit regulatorischen Eigenschaften sowie die IgE-vermittelte Autoimmunität werden in naher Zukunft wichtige Informationen über die defekte Toleranz bei atopischen Patienten liefern und möglicherweise neue Wege zur Prävention und Therapie aufzeichnen.
Abstract
The incidence of atopic dermatitis (AD) is noticeably increasing in industrialized countries. New insights into the pathogenesis of this disease are mirrored by a changed terminology suggested by the World Allergy Organization: a distinction between a so-called atopic and non-atopic dermatitis. The pathogenesis of the AD, which this article concentrates on, is highly complex. Genetic and environmental factors play a pivotal role in triggering AD. The complex pattern of cytokines and chemokines, reflecting a deviated immune response in AD patients, is a focus of research, as are the involvement of various cells and the epidermal barrier. Research concerning T cells with regulatory features as well as IgE-mediated autoreactivity will soon give insight into the defective tolerance of atopic patients and might possibly lead to new concepts in the management of the disease.
Literatur
Cookson WO (2004) The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 4: 978–988
Darsow U, Laifaoui J, Kerschenlohr K et al. (2004) The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy 59: 1318–1325
Echigo T, Hasegawa M, Shimada Y et al. (2004) Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation. J Allergy Clin Immunol 113: 940–948
Hijnen D, De Bruin-Weller M, Oosting B et al. (2004) Serum Thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 113: 334–340
Hoffjan S, Epplen JT (2005) The genetics of atopic dermatitis: recent findings and future options. J Mol Med 83(9): 682–692
Holgate ST (1998) The epedemic of allergy and asthma. Nature 402: B2–B4
Kato A (2003) Association of SPINK5 gene polymorphismus with atopic dermatitis in Japanese population. Br J Dermatol 148: 665–669
Klunker S, Trautmann A, Akdis M et al. (2003) A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis towards epidermis in atopic dermatitis. J Immunol 171: 1078–1084
Leung DY, Bieber T (2003) Atopic dermatitis. Lancet 361: 151–160
Leung DY, Boguniewicz M, Howell MD et al. (2004) New insights into atopic dermatitis. J Clin Invest 113: 651–657
Liu X (2003) Associations between total serum IgE levels and the 6 potentially functional variants within the genes IL-4, IL-13, and IL4RA in German children: the German Multicenter Atopy Study. J Allergy Clin Immunol 112: 382–388
Mothes N, Niggemann B, Jenneck C et al. (2005) The cradle of IgE hypersensitivity in atopic eczema lies in infancy. J Allergy Clin Immunol 116: 706–709
Novak N, Allam JP, Hagemann T et al. (2004) Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J Allergy Clin Immunol 114: 364–370
Novak N, Bieber T (2003) Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 112: 252–262
Ong PY, Ohtake T, Brandt C et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347: 1151–1160
Raap U, Goltz C, Deneka N et al. (2005) Brain-derived neurotrophic factor is increased in atopic eczema and modulates eosinophil functions compared with that seen in nonatopic subjects. J Allergy Clin Immunol 115: 1268–1275
Rippke F, Schreiner V, Doering T, Maibach HI (2004) Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus aureus. Am J Clin Dermatol 5: 217–223
Schmid-Grendelmeier P, Fluckiger S, Disch R et al. (2005) IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol 115: 1068–1075
Schmid-Ott G, Jaeger B, Adamek C et al. (2001) Levels of circulating CD8+ T-lymphocytes, natural killer cells and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. J Allergy Clin Immunol 107: 171–177
Schultz-Larsen F, Hanifin JM (2002) Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 22: 1–24
Simon D, Braathen LR, Simon HU (2004) Eosinophils and atopic dermatitis. Allergy 59: 561–570
Sonkoly E, Muller A, Lauerma AI et al. (2006) IL-31: A new link between T cells and Pruritus in atopic skin inflammation. J Allergy Clin Immunol 117: 411–417
Takaoka A, Arai I, Sugimoto M et al. (2005) Expression of IL-13 gene transcripts in NC/Nga mice with atopic dermatitis. Eur J Pharmacol 516: 180–181
Toyoda M, Nakamura M, Makino T et al. (2002) Nerve growth factor and the substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 147: 71–79
Vasilopoulos Y, Cork MJ, Murphy R et al. (2004) Genetic association between an AACC insertion in the 3’UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 123: 62–66
Yoo J, Omori M, Gyarmati D et al. (2005) Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 202: 541–549
Interessenkonflikt
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hinz, T., Staudacher, A. & Bieber, T. Neues in der Pathophysiologie der atopischen Dermatitis. Hautarzt 57, 567–575 (2006). https://doi.org/10.1007/s00105-006-1175-y
Issue Date:
DOI: https://doi.org/10.1007/s00105-006-1175-y